Home 
HOME Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.6, p.429–433, 2019
HOME Bratislava Medical Journal 2019 Bratislava Medical Journal Vol.120, No.6, p.429–433, 2019
Journal info
|
||||
Select Journal
Journals
Bratislava Medical Journal 2024 Ahead of print 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 Endocrine Regulations General Physiology and Biophysics Neoplasma Acta Virologica Studia Psychologica Cardiology Letters Psychológia a patopsych. dieťaťa Kovove Materialy-Metallic Materials Slovenská hudbaWebshop Cart
Your Cart is currently empty.
Info: Your browser does not accept cookies. To put products into your cart and purchase them you need to enable cookies.
Bratislava Medical Journal Vol.120, No.6, p.429–433, 2019 |
||
| Title: The alpha-2 receptor agonist dexmedetomidine attenuates vancomycin‑induced acute kidney injury | ||
| Author: A. Bayram, G. N. Erkan, G. Talih, G. Baskol, K. Deniz, K. Yildiz, A. Esmaoglu | ||
| Abstract: OBJECTIVE: This study was conducted to evaluate the protective effect of dexmedetomidine on nephrotoxicity and the mechanism of renoprotection following vancomycin-induced nephrotoxicity in rats. METHODS: Thirty-two albino Wistar rats were divided into four groups. The control group received intraperitoneal (IP) physiological saline solution, the vancomycin (VMC) group received IP 200 mg/kg vancomycin, the dexmedetomidine (DEX) group received IP 5 µg/kg dexmedetomidine, and the vancomycin and dexmedetomidine (VMC+DEX) group received IP 200 mg/kg vancomycin followed by IP 5 µg/kg dexmedetomidine 20 min after the vancomycin injection. On the 8th day of the experiment, histopathological and biochemical parameters were assessed. RESULTS: Creatinine levels were significantly higher in VMC and VMC+DEX groups. The endothelin-1 level was significantly higher in VMC group. Nitric oxide levels were statistically lower in VMC and VMC+DEX groups. Histopathologic assessments revealed that the extent of renal damage was significantly higher in group VMC (n = 4 with damage of Grade 3) compared to group VMC+DEX (n = 0 with damage of Grade 3). CONCLUSION: It was determined that dexmedetomidine can reduce the extent of renal damage by preventing the elevation of vasoconstrictor agents (Tab. 2, Fig. 1, Ref. 36). |
||
| Keywords: dexmedetomidine, nephrotoxicity, rat, vancomycin, vasoconstriction, vasodilation | ||
| Published online: 21-Jun-2019 | ||
| Year: 2019, Volume: 120, Issue: 6 | Page From: 429, Page To: 433 | |
| doi:10.4149/BLL_2019_069 |
||
|
|
 download file |
|